More evidence blood-thinners could fight Covid-19: Drugs boost survival odds by up to 50%

The study by researchers in New York found the best outcomes for apixaban, sold under the brand name Eliquis, and low molecular weight heparins (LMWHs), such as Fragmin.

from Health News | Mail Online https://ift.tt/3gwRRyv